Profusa, Inc. (PFSA): Cash & Equivalents
$1.78M
As of 2025-12-31
+109.5%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.78M | +830.9% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $191.0K | n/m | 2026-04-15, Balance as of period end |
| 2023-12-31 | $4.5K | -97.7% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $193.5K | n/a | 2024-02-26, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Profusa, Inc. (PFSA) | 2025-12-31 | $1.78M | +830.9% |
| Encision Inc (ECIA) | 2025-03-31 | $257.4K | +505.6% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $1.35M | -45.6% |
| QTREX Quantum Ltd. (QTEX) | 2025-12-31 | $3.16M | -38.2% |
| HeartBeam, Inc. (BEATW) | 2025-12-31 | $4.38M | +84.3% |
| Aethlon Medical Inc (AEMD) | 2026-03-31 | $5.03M | -8.6% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $149.8K | -59.0% |
| QHSLab, Inc. (USAQ) | 2025-12-31 | $636.2K | +304.8% |
| Bluejay Diagnostics, Inc. (BJDX) | 2025-12-31 | $5.16M | +20.1% |
Compare PFSA, ECIA, HRGN, QTEX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗